【结 构 式】 |
【分子编号】39749 【品名】3,4-dihydroxybenzaldehyde 【CA登记号】139-85-5 |
【 分 子 式 】C7H6O3 【 分 子 量 】138.12284 【元素组成】C 60.87% H 4.38% O 34.75% |
合成路线1
该中间体在本合成路线中的序号:(XVI)Protection of 3,4-dihydroxybenzaldehyde (XVI) with t-butyldimethylsilyl chloride and imidazole provided the corresponding bis-silyl ether (XVII) (2). Asymmetric nitroaldol condensation of aldehyde (XVII) with nitromethane in the presence of the chiral samarium tris(binaphthoxide) complex (XV) --prepared from (S)-6,6'-bis(trimethylsilylethynyl)-1,1'-dihydroxy-2,2'-binaphthalene (XIV) and samarium triisopropoxide in the presence of BuLi (2,3)-- gave rise to the (R)-nitro alcohol adduct (XVIII) with high optical purity. Catalytic hydrogenation of the nitro group of (XVIII) furnished the silylated norepinephrine (XIX), which was coupled with acid (XIII) in the presence of diethylphosphoryl cyanide to yield amide (XX). Reduction of amide (XX) with LiAlH4 gave amine (XXI). The silyl and methoxymethyl protecting groups were finally removed under acidic conditions to furnish the title compound.
【1】 Takaoka, E.; et al.; Catalytic asymmetric synthesis of arbutamine. Heterocycles 1997, 46, 157. |
【2】 Shibasaki, M.; Fujita, M.; Urata, Y.; Sasai, H. (Chisso Corp.); Optically active nitro alcohol derivs., optically active amino alcohol derivates, and process for preparing the same. EP 0947498; WO 9824753 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XIII) | 55601 | 4-[4-(methoxymethoxy)phenyl]butanoic acid | C12H16O4 | 详情 | 详情 | |
(XIV) | 55603 | C30H30O2Si2 | 详情 | 详情 | ||
(XV) | 55604 | C90H84Li3O6Si6Sm | 详情 | 详情 | ||
(XVI) | 39749 | 3,4-dihydroxybenzaldehyde | 139-85-5 | C7H6O3 | 详情 | 详情 |
(XVII) | 55602 | 3,4-bis{[tert-butyl(dimethyl)silyl]oxy}benzaldehyde | C19H34O3Si2 | 详情 | 详情 | |
(XVIII) | 55605 | (1R)-1-(3,4-bis{[tert-butyl(dimethyl)silyl]oxy}phenyl)-2-nitro-1-ethanol | C20H37NO5Si2 | 详情 | 详情 | |
(XIX) | 55606 | (1R)-2-amino-1-(3,4-bis{[tert-butyl(dimethyl)silyl]oxy}phenyl)-1-ethanol | C20H39NO3Si2 | 详情 | 详情 | |
(XX) | 55607 | N-[(2R)-2-(3,4-bis{[tert-butyl(dimethyl)silyl]oxy}phenyl)-2-hydroxyethyl]-4-[4-(methoxymethoxy)phenyl]butanamide | C32H53NO6Si2 | 详情 | 详情 | |
(XXI) | 55608 | (1R)-1-(3,4-bis{[tert-butyl(dimethyl)silyl]oxy}phenyl)-2-({4-[4-(methoxymethoxy)phenyl]butyl}amino)-1-ethanol | C32H55NO5Si2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(IV)Reaction of methyl cyanoacetate (I) with benzylamine (II) at 100 C gives N-benzyl cyanoacetamide (III). Subsequent condensation of (III) with 3,4-dihydroxybenzaldehyde (IV) in the presence of NaH provides the title compound.
【1】 Gazit, A.; et al.; Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J Med Chem 1991, 34, 6, 1896. |
合成路线3
该中间体在本合成路线中的序号:(III)The title compound was obtained by condensation between 9-ethylcarbazole-3-carboxaldehyde (I), veratraldehyde (III), and O,O'-diaminoethanediol (II). The desired asymmetric bisoxime was separated from the symmetric homodimers by silica gel column chromatography.
【1】 Choong, I.C.; Dustin, J.; Ellman, J.A.; Combinatorial target-guided ligand assembly: Identification of potent subtype-selective c-Src inhibitors. Proceedings of the National Academy of Sciences of the United States of America 2000, 97, 6, 2419. |
合成路线4
该中间体在本合成路线中的序号:(IV)Metallation of 1,4-dibromobenzene (I) followed by addition to hexafluoroacetone afforded the bis(trifluoromethyl)carbinol (II), which was subsequently protected as the trimethylsilylethoxymethyl ether (III). 3,4-Dihydroxybenzaldehyde (IV) was alkylated with either chlorodifluoromethane or methyl chlorodifluoroacetate to give the bis(difluoromethyl)ether (V). Addition of either the organolithium or Grignard reagent prepared from aryl bromide (III) to aldehyde (V) furnished the diaryl carbinol (VI), which was converted to chloride (VII) by treatment with SOCl2 and diisopropyl ethylamine. Selective carbomethoxylation of 3,4-dimethylpyridine (VIII) using dimethyl carbonate and LDA afforded (IX). Condensation of chloride (VII) with the lithium anion of (IX) yielded the triarylpropionate derivative (X). Ester group hydrolysis with LiOH, followed by acidification with NH4Cl, provided the decarboxylated compound (XI). After SEM group cleavage by treatment with tetrabutylammonium fluoride, the pyridine ring of the resulting (XII) was finally oxidized to the target N-oxide.
【2】 Guay, D.; Ducharme, Y.; Blouin, M.; Hamel, P.; Girard, M. (Merck Frosst Canada Inc.); Tri-aryl ethane derivs. as PDE IV inhibitors. EP 0873311; JP 2000501742; US 5710170; WO 9722586 . |
【1】 Brideau, C.; Ducharme, Y.; Blouin, M.; et al.; Substituted 4-(2,2-diphenylethyl)pyridine-N-oxides as phosphodiesterase-4 inhibitors: SAR study directed toward the improvement of pharmacokinetic parameters. 16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000, Abst PB-12. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 18983 | 1,4-dibromobenzene | 106-37-6 | C6H4Br2 | 详情 | 详情 |
(II) | 45834 | 2-(4-bromophenyl)-1,1,1,3,3,3-hexafluoro-2-propanol | C9H5BrF6O | 详情 | 详情 | |
(III) | 45835 | [1-(4-bromophenyl)-2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methyl 2-(trimethylsilyl)ethyl ether; (2-[[1-(4-bromophenyl)-2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methoxy]ethyl)(trimethyl)silane | C15H19BrF6O2Si | 详情 | 详情 | |
(IV) | 39749 | 3,4-dihydroxybenzaldehyde | 139-85-5 | C7H6O3 | 详情 | 详情 |
(V) | 45836 | 3,4-bis(difluoromethoxy)benzaldehyde | C9H6F4O3 | 详情 | 详情 | |
(VI) | 45837 | [3,4-bis(difluoromethoxy)phenyl][4-(2,2,2-trifluoro-1-(trifluoromethyl)-1-[[2-(trimethylsilyl)ethoxy]methoxy]ethyl)phenyl]methanol | 597-43-3 | C24H26F10O5Si | 详情 | 详情 |
(VII) | 45838 | [1-[4-[[3,4-bis(difluoromethoxy)phenyl](chloro)methyl]phenyl]-2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methyl 2-(trimethylsilyl)ethyl ether; (2-[[1-[4-[[3,4-bis(difluoromethoxy)phenyl](chloro)methyl]phenyl]-2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methoxy]ethyl)(trimethyl)silane | C24H25ClF10O4Si | 详情 | 详情 | |
(VIII) | 39869 | 3,4-dimethylpyridine | 583-58-4 | C7H9N | 详情 | 详情 |
(IX) | 45839 | methyl 2-(3-methyl-4-pyridinyl)acetate | C9H11NO2 | 详情 | 详情 | |
(X) | 45840 | methyl 3-[3,4-bis(difluoromethoxy)phenyl]-2-(3-methyl-4-pyridinyl)-3-[4-(2,2,2-trifluoro-1-(trifluoromethyl)-1-[[2-(trimethylsilyl)ethoxy]methoxy]ethyl)phenyl]propanoate | C33H35F10NO6Si | 详情 | 详情 | |
(XI) | 45841 | 4-[2-[3,4-bis(difluoromethoxy)phenyl]-2-[4-(2,2,2-trifluoro-1-(trifluoromethyl)-1-[[2-(trimethylsilyl)ethoxy]methoxy]ethyl)phenyl]ethyl]-3-methylpyridine; [1-[4-[1-[3,4-bis(difluoromethoxy)phenyl]-2-(3-methyl-4-pyridinyl)ethyl]phenyl]-2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methyl 2-(trimethylsilyl)ethyl ether | C31H33F10NO4Si | 详情 | 详情 | |
(XII) | 45842 | 2-[4-[1-[3,4-bis(difluoromethoxy)phenyl]-2-(3-methyl-4-pyridinyl)ethyl]phenyl]-1,1,1,3,3,3-hexafluoro-2-propanol | C25H19F10NO3 | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号:(I)
【1】 Chandregowda V,Rao GV, et aL 2007. One-pot conversion of 2-nitrobenzonitriles to quinazolin-4 (3H)-ones and synthesis of gefitinib and erlotinib hydrochloride. Heterocycles, 71: 39~48 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 39749 | 3,4-dihydroxybenzaldehyde | 139-85-5 | C7H6O3 | 详情 | 详情 |
(II) | 66352 | 3,4-bis(2-methoxyethoxy)benzaldehyde | C13H18O5 | 详情 | 详情 | |
(III) | 66353 | 3,4-bis(2-methoxyethoxy)benzonitrile | C13H17NO4 | 详情 | 详情 | |
(IV) | 66354 | 4,5-bis(2-methoxyethoxy)-2-nitrobenzonitrile | 236750-65-5 | C13H16N2O6 | 详情 | 详情 |
(V) | 66355 | 2-amino-4,5-bis(2-methoxyethoxy)benzonitrile | C13H18N2O4 | 详情 | 详情 | |
(VI) | 56443 | 6,7-bis(2-methoxyethoxy)-4(3H)-quinazolinone | 179688-29-0 | C14H18N2O5 | 详情 | 详情 |